QMJC May 2022: Investigating the practice of microdosing psychedelics
The latest discussion from the Qualitative Methods Journal Club is now available online, focusing on a study about the experience and rationale for microdosing psychedelics, such as LSD and psilocybin.
In May 2022, members of the Department of Community Health and Prevention at Drexel University (Philadelphia, United States) took on hosting duties for the Qualitative Methods Journal Club (QMJC).
A central focus of discussion within the group was the framing of microdosing as “embracing middle-class values”, and more compatible with the notion of being a “productive citizen” due to the “controlled manner” in which participants said they took drugs.
“Perhaps due to their privilege as white and middle-class, the participants did not need to explicitly distance themselves from the stigmatising labels often associated with people who use drugs, which is often the case for people of colour and/or people living more economically-disadvantaged lives.”
Original article: Narrative identity, rationality, and microdosing classic psychedelics. By Megan Webb and colleagues. Published in the International Journal of Drug Policy (2019).
The opinions expressed in this post reflect the views of the author(s) and do not necessarily represent the opinions or official positions of the SSA.
The SSA does not endorse or guarantee the accuracy of the information in external sources or links and accepts no responsibility or liability for any consequences arising from the use of such information.